These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 25351424)

  • 1. Familial tumoral calcinosis.
    Alkhatib A; Burton LE; Carachi R
    Scott Med J; 2014 Nov; 59(4):e17-20. PubMed ID: 25351424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to acetazolamide in a patient with tumoral calcinosis.
    Landini-Enríquez V; Escamilla MA; Soto-Vega E; Chamizo-Aguilar K
    Nefrologia; 2015; 35(5):503-5. PubMed ID: 26388352
    [No Abstract]   [Full Text] [Related]  

  • 3. Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer.
    Lammoglia JJ; Mericq V
    Horm Res; 2009; 71(3):178-84. PubMed ID: 19188744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms.
    Finer G; Price HE; Shore RM; White KE; Langman CB
    Am J Med Genet A; 2014 Jun; 164A(6):1545-9. PubMed ID: 24668887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive.
    Ichikawa S; Lyles KW; Econs MJ
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2420-3. PubMed ID: 15687324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Successful Treatment of Deep Soft-tissue Calcifications with Topical Sodium Thiosulphate and Acetazolamide in a Boy with Hyperphosphatemic Familial Tumoral Calcinosis due to a Novel Mutation in
    Döneray H; Özden A; Gürbüz K
    J Clin Res Pediatr Endocrinol; 2022 Jun; 14(2):239-243. PubMed ID: 33685073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment approaches for tumoral calcinosis in children and young people: A condition of diverse pathogenesis.
    Anilkumar A; Högler W; Bursell J; Nadar R; Ryan F; Randell T; Shaw NJ; Uday S
    Bone; 2024 May; 182():117049. PubMed ID: 38364881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperostosis with hyperphosphatemia and tumoral calcinosis: a case report.
    Otukesh H; Hoseini R; Chalian H; Chalian M; Safarzadeh AE; Shakiba M; Poorian A
    Pediatr Nephrol; 2007 Aug; 22(8):1235-7. PubMed ID: 17437133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperphosphatemic Familial Tumoral Calcinosis in Two Siblings with a Novel Mutation in
    Kışla Ekinci RM; Gürbüz F; Balcı S; Bişgin A; Taştan M; Yüksel B; Yılmaz M
    J Clin Res Pediatr Endocrinol; 2019 Feb; 11(1):94-99. PubMed ID: 30015621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature.
    Chakhtoura M; Ramnitz MS; Khoury N; Nemer G; Shabb N; Abchee A; Berberi A; Hourani M; Collins M; Ichikawa S; El Hajj Fuleihan G
    Osteoporos Int; 2018 Sep; 29(9):1987-2009. PubMed ID: 29923062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.
    Garringer HJ; Fisher C; Larsson TE; Davis SI; Koller DL; Cullen MJ; Draman MS; Conlon N; Jain A; Fedarko NS; Dasgupta B; White KE
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4037-42. PubMed ID: 16868048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis.
    Larsson T; Yu X; Davis SI; Draman MS; Mooney SD; Cullen MJ; White KE
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2424-7. PubMed ID: 15687325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features.
    Dumitrescu CE; Kelly MH; Khosravi A; Hart TC; Brahim J; White KE; Farrow EG; Nathan MH; Murphey MD; Collins MT
    Osteoporos Int; 2009 Jul; 20(7):1273-8. PubMed ID: 18982401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysis as a Treatment Option for a Patient With Normal Kidney Function and Familial Tumoral Calcinosis Due to a Compound Heterozygous FGF23 Mutation.
    Goldenstein PT; Neves PD; Balbo BE; Elias RM; Pereira AC; Onuchic LF; Jüppner H; Jorgetti V; Abensur H; Moysés RM
    Am J Kidney Dis; 2018 Sep; 72(3):457-461. PubMed ID: 29548779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial tumoral calcinosis: a forty-year follow-up on one family.
    Carmichael KD; Bynum JA; Evans EB
    J Bone Joint Surg Am; 2009 Mar; 91(3):664-71. PubMed ID: 19255228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis.
    Masi L; Gozzini A; Franchi A; Campanacci D; Amedei A; Falchetti A; Franceschelli F; Marcucci G; Tanini A; Capanna R; Brandi ML
    J Bone Joint Surg Am; 2009 May; 91(5):1190-8. PubMed ID: 19411468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial tumoral calcinosis: a rare autosomal recessive disease.
    Moran H; Malvar M; Yuksel S; Bleich D
    BMJ Case Rep; 2024 Oct; 17(10):. PubMed ID: 39395830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic transmission of tumoral calcinosis: autosomal dominant with variable clinical expressivity.
    Lyles KW; Burkes EJ; Ellis GJ; Lucas KJ; Dolan EA; Drezner MK
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1093-6. PubMed ID: 3998061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Familial tumoral calcinosis in three patients in the same family].
    Yurdoğlu C; Ozbaydar MU; Adaş M; Ozger H
    Acta Orthop Traumatol Turc; 2007; 41(3):244-8. PubMed ID: 17876123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed.
    Larsson T; Davis SI; Garringer HJ; Mooney SD; Draman MS; Cullen MJ; White KE
    Endocrinology; 2005 Sep; 146(9):3883-91. PubMed ID: 15961556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.